These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Challenges in developing mucosal vaccines and antibodies against infectious diarrhea in children. Tokuhara D Pediatr Int; 2018 Mar; 60(3):214-223. PubMed ID: 29290097 [TBL] [Abstract][Full Text] [Related]
45. Adjuvants and delivery issues related to immunization: a survey of the recent patent literature. Mrsny RJ J Drug Target; 1998; 6(4):243-9. PubMed ID: 9894692 [TBL] [Abstract][Full Text] [Related]
46. Recombinant Newcastle disease virus-vectored vaccines against human and animal infectious diseases. Duan Z; Xu H; Ji X; Zhao J Future Microbiol; 2015; 10(8):1307-23. PubMed ID: 26234909 [TBL] [Abstract][Full Text] [Related]
48. Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine. Luke TC; Hoffman SL J Exp Biol; 2003 Nov; 206(Pt 21):3803-8. PubMed ID: 14506215 [TBL] [Abstract][Full Text] [Related]
49. Vaccination Strategies against Malaria: novel carrier(s) more than a tour de force. Tyagi RK; Garg NK; Sahu T J Control Release; 2012 Aug; 162(1):242-54. PubMed ID: 22564369 [TBL] [Abstract][Full Text] [Related]
50. RNA based vaccines. Cannon G; Weissman D DNA Cell Biol; 2002 Dec; 21(12):953-61. PubMed ID: 12573052 [TBL] [Abstract][Full Text] [Related]
51. Mucosal responses to parenteral and mucosal vaccines. Kaul D; Ogra PL Dev Biol Stand; 1998; 95():141-6. PubMed ID: 9855424 [TBL] [Abstract][Full Text] [Related]
55. Novel ELISA method as exploratory tool to assess immunity induced by radiated attenuated sporozoites to decipher protective immunity. Knepper TA; Duncan EH; Savransky T; Bergmann-Leitner ES Malar J; 2017 Nov; 16(1):484. PubMed ID: 29187199 [TBL] [Abstract][Full Text] [Related]
56. Vaccine technologies: From whole organisms to rationally designed protein assemblies. Karch CP; Burkhard P Biochem Pharmacol; 2016 Nov; 120():1-14. PubMed ID: 27157411 [TBL] [Abstract][Full Text] [Related]
57. Dendritic cell discoveries provide new insight into the cellular immunobiology of DNA vaccines. Coombes BK; Mahony JB Immunol Lett; 2001 Sep; 78(2):103-11. PubMed ID: 11672594 [TBL] [Abstract][Full Text] [Related]
58. Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies. Nelson WG; Simons JW; Mikhak B; Chang JF; DeMarzo AM; Carducci MA; Kim M; Weber CE; Baccala AA; Goeman MA; Clift SM; Ando DG; Levitsky HI; Cohen LK; Sanda MG; Mulligan RC; Partin AW; Carter HB; Piantadosi S; Marshall FF Cancer Chemother Pharmacol; 2000; 46 Suppl():S67-72. PubMed ID: 10950151 [TBL] [Abstract][Full Text] [Related]
59. Assessing the Importance of Domestic Vaccine Manufacturing Centers: An Overview of Immunization Programs, Vaccine Manufacture, and Distribution. Rey-Jurado E; Tapia F; Muñoz-Durango N; Lay MK; Carreño LJ; Riedel CA; Bueno SM; Genzel Y; Kalergis AM Front Immunol; 2018; 9():26. PubMed ID: 29403503 [TBL] [Abstract][Full Text] [Related]